RESMED INC — Director's Dealing 2010

Feb 24, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-02-22

Reporting Person: WAREHAM JOHN P (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-02-22	ResMed Common Stock	M	18000	$24.9350	Acquired	18000	Direct
2010-02-22	ResMed Common Stock	S	13000	$57.971	Disposed	5000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-02-22	ResMed NQ Stock Options	$24.935	M	18000	Disposed	2015-01-20	ResMed Common Stock (18000)	Direct

Footnotes

F1: Represents date options first became exercisable.

F2: We previously reported an aggregated amount of derivative securities beneficially owned. We are now reporting only those derivative securities beneficially owned that are of the same class as those disposed of in this trade -- identified by the SEC to be those that have the same grant date and exercise price.

F3: This transaction was executed in multiple trades at prices ranging from 57.96 to $57.98. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.